A Study to Determine the Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Non-anemic Patients Who Are Undergoing Orthopedic, Heart and Blood Vessel, or Breast Reduction Surgery; Performed in Combination With a Procedure to Reduce Blood Loss During Surgery.

Clinical trial NCT00270023 · COMPLETED

Trial details

NCT number: NCT00270023
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Blood Transfusion Blood Transfusion, Autologous Orthopedic Procedures Orthopedic Surgery Cardiovascular Surgical Procedures Mammaplasty

Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.